Adriamycin-induced, TNF-α-mediated central nervous system toxicity
The clinical effectiveness of adriamycin (ADR), a potent chemotherapeutic, is known to be limited by severe cardiotoxic side effects. However, the effect of ADR on brain tissue is not well understood. It is generally thought that ADR is not toxic to the brain because ADR does not pass the blood–brai...
Main Authors: | Jitbanjong Tangpong, Marsha P. Cole, Rukhsana Sultana, Gururaj Joshi, Steven Estus, Mary Vore, William St. Clair, Suvina Ratanachaiyavong, Daret K. St. Clair, D. Allan Butterfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-07-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996106000404 |
Similar Items
-
Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer
by: Yumin Wei, et al.
Published: (2023-06-01) -
The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
by: Ying Zhu, et al.
Published: (2013-11-01) -
Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
by: Le Van Manh Hung, et al.
Published: (2018-03-01) -
Adriamycin-induced fetal hydronephrosis
by: Anderson Gonçalves, et al.
Published: (2004-12-01) -
Lisinopril Protects Against the Adriamycin Nephropathy and Reverses the Renalase Reduction: Potential Role of Renalase in Adriamycin Nephropathy
by: Pengxun Han, et al.
Published: (2013-09-01)